6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.

Funding Neuspera Medical, a US-based neuromodulation system developer backed by pharmaceutical firm WuXi AppTec, completed a $65m series C round yesterday that was co-led by Vertex Ventures and Treo Ventures and which included Action Potential Venture Capital and Windham Venture Partners. The company had previously raised about $36m, closing a $26m series B round in…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.